187 related articles for article (PubMed ID: 29313235)
1. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
[TBL] [Abstract][Full Text] [Related]
3. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
4. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
Gao YC; Wu J
Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
Gong L; Wang C; Gao Y; Wang J
Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
[TBL] [Abstract][Full Text] [Related]
10. Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer.
Zhang X; Zhang H
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):837-41. PubMed ID: 27010138
[TBL] [Abstract][Full Text] [Related]
11. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through
Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I
Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.].
Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA
Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550
[TBL] [Abstract][Full Text] [Related]
15. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
[TBL] [Abstract][Full Text] [Related]
16. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H
Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886
[TBL] [Abstract][Full Text] [Related]
19. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
20. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
